AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
OMEPRAZOLE USP
7 registrations across 4 African markets— 5 active
Markets with OMEPRAZOLE USP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Omezole Capsule, Hard | 🇰🇪Kenya | Jaysheel Patel | active | Feb 2029 |
| MEPACID-20 CAPSULES | 🇬🇭Ghana | — | active | Sept 2027 |
| MEPACID-20 CAPSULES | 🇬🇭Ghana | — | active | Sept 2027 |
| GALEN'S OMEPRAZOLE DELAYED- RELEASE CAPSULE 20MG CAPSULE | 🇳🇬Nigeria | CARE PHARM LTD 6 | expired | Apr 2023 |
| ODASOL-20 CAPSULES CAPSULE | 🇳🇬Nigeria | CIFAX EXIM LIMITED 20 | expired | Apr 2021 |
| SOLCER SR comprimé / 20 mg | 🇸🇳Senegal | STRIDES PHARMA SCIENCE LIMITED, BILEKAHALLI, BANNERGHATTA ROAD, BANGALORE-560076, INDE | active | — |
| SOLCER SR comprimé / 20 mg | 🇸🇳Senegal | STRIDES PHARMA SCIENCE LIMITED, BILEKAHALLI, BANNERGHATTA ROAD, BANGALORE-560076, INDE | active | — |
OMEPRAZOLE USP in Africa — Regulatory Overview
OMEPRAZOLE USP is registered across 4 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Nigeria, Senegal, Kenya. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 5 (71%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.